Your browser doesn't support javascript.
loading
EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.
Maslova, Kseniya; Kyriakakis, Emmanouil; Pfaff, Dennis; Frachet, Audrey; Frismantiene, Agne; Bubendorf, Lukas; Ruiz, Christian; Vlajnic, Tatjana; Erne, Paul; Resink, Thérèse J; Philippova, Maria.
Afiliação
  • Maslova K; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Kyriakakis E; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Pfaff D; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Frachet A; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Frismantiene A; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Bubendorf L; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Ruiz C; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Vlajnic T; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Erne P; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Resink TJ; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland therese-j.resink@unibas.ch.
  • Philippova M; *Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.
FASEB J ; 29(2): 494-507, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25381040
ABSTRACT
T-cadherin is an atypical glycosylphosphatidylinsoitol-anchored member of the cadherin superfamily of adhesion molecules. We found that T-cadherin overexpression in malignant (DU145) and benign (BPH-1) prostatic epithelial cell lines or silencing in the BPH-1 cell line, respectively, promoted or inhibited migration and spheroid invasion in collagen I gel and Matrigel. T-cadherin-dependent effects were associated with changes in cell phenotype overexpression caused cell dissemination and loss of polarity evaluated by relative positioning of the Golgi/nuclei in cell groups, whereas silencing caused formation of compact polarized epithelial-like clusters. Epidermal growth factor receptor (EGFR) and IGF factor-1 receptor (IGF-1R) were identified as mediators of T-cadherin effects. These receptors per se had opposing influences on cell phenotype. EGFR activation with EGF or IGF-1R inhibition with NVP-AEW541 promoted dissemination, invasion, and polarity loss. Conversely, inhibition of EGFR with gefitinib or activation of IGF-1R with IGF-1 rescued epithelial morphology and decreased invasion. T-cadherin silencing enhanced both EGFR and IGF-1R phosphorylation, yet converted cells to the morphology typical for activated IGF-1R. T-cadherin effects were sensitive to modulation of EGFR or IGF-1R activity, suggesting direct involvement of both receptors. We conclude that T-cadherin regulates prostate cancer cell behavior by tuning the balance in EGFR/IGF-1R activity and enhancing the impact of IGF-1R.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata / Caderinas / Receptor IGF Tipo 1 / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata / Caderinas / Receptor IGF Tipo 1 / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article